<DOC>
	<DOCNO>NCT01799863</DOCNO>
	<brief_summary>The purpose study evaluate evolution symptom acute viral conjunctivitis use preservative free ketorolac trometamol 0.45 % associate carboxymethylcellulose compare isolated use preservative-free artificial tear .</brief_summary>
	<brief_title>Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45 % Acute Viral Conjunctivitis</brief_title>
	<detailed_description>The purpose study evaluate evolution symptom acute viral conjunctivitis use preservative free ketorolac trometamol 0.45 % associate carboxymethylcellulose compare isolated use preservative-free artificial tear . A randomized double-masked study include 60 patient divide two group : Group 1 : use formulation ketorolac tromethamine 0.45 % associate carboxymethylcellulose ( Acular CMC® , Allergan , Irvine , USA ) Group 0 : use artificial tear ( Optive UD® , Allergan , Irvine , USA ) , drug without preservative .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Viral</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Acute conjunctivitis ( unilateral bilateral ) less two week , Signs symptoms consistent viral conjunctivitis least one following : preauricular lymphadenopathy , upper tract respiratory infection recent contact someone conjunctivitis pregnant woman allergy nonsteroidal antiinflammatories history seasonal allergic conjunctivitis contact lens wearer history ocular herpes infection blepharitis severe dry eye purulent discharge defect corneal epithelium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Conjunctivitis , Viral</keyword>
	<keyword>Ketorolac</keyword>
	<keyword>Artificial tear</keyword>
</DOC>